Scaffolding proteins organize the information flow from activated G protein-coupled receptors (GPCRs) to intracellular effector cascades spatially and temporally. By this means signaling scaffolds such as A-kinase anchoring proteins (AKAPs) compartmentalize kinase activities and ensure substrate selectivity. Using a phosphoproteomics approach we identified a physical and functional connection between protein kinase A (PKA) and GPR161 signaling. We show that the orphan GPCR GPR161 on its own contains the structural features to function as high-affinity type I AKAP. Binary complex formation affects plasma membrane targeting in cells and provokes GPR161-mediated PKA recruitment into the primary cilium of zebra fish embryos. We illustrate that receptor-anchored PKA complexes enhance cAMP-mediated GPR161 phosphorylation, which is regarded as one general principal for regulating GPCR desensitization. In addition, we unveiled that distinct disease mutations of PKA regulatory subunits differentially contribute to spatially restricted interactions of GPR161-anchored PKA type I holoenzyme complexes. Thus, the integrity of the membrane-targeted and cAMPsensing GPR161:PKA signalosome needs to be considered in analyzing, interpreting, and pharmaceutical targeting of GPR161-involved and PKA-associated human diseases.
Introduction
Scaffolding proteins act as flexible organizing centers to consolidate and propagate the cellular information flow from activated cell-surface receptors to intracellular effector cascades. Activated G protein-coupled receptors (GPCRs) engage pleiotropic scaffolds such as beta-arrestin and A-kinase anchoring proteins (AKAPs) to recruit cytoplasmic downstream effector molecules [1] [2] [3] [4] [5] . Thus compartmentalized GTPases, kinases and phosphatases act as GPCR-linked molecular switches to spatially and temporally control signal propagation. In the classical view of GPCR signaling, extracellular ligands bind to the receptor which catalyzes the intracellular GDP/GTP exchange and activation of receptor-associated trimeric G protein () combinations 3 . In addition to receptor dimerization, GPCR signaling and trafficking involve G protein-dependent and G proteinindependent intracellular interactions with scaffolds such as beta-arrestin and AKAPs 1, 2, 6, 7 . Receptor-interacting proteins and kinase activities contribute to the fine-tuning of GPCR localization and activities 5, [8] [9] [10] . Different AKAPs coordinate and compartmentalize diffusible second messenger responses through anchoring of cAMP-dependent type I or type II protein kinase A (PKA) holoenzymes, composed of two regulatory (RIor RII) and two catalytic (PKAc) subunits, to discrete subcellular localizations 11 . The four R subunits have different expression patterns and are functionally non-redundant. The growing family of AKAPs are functionally diverse; however, all AKAPs contain an amphipathic helix, which account for nano-molar binding affinities to PKA R subunit dimers 12, 13 . Moreover, it has been shown that additional components of the cAMP signaling machinery physically interact with AKAPs, such as GPCRs, adenylyl cyclases (ACs) and phosphodiesterases (PDEs) 1, 6, [14] [15] [16] . Deregulation of the GPCR-cAMP-PKA pathways contribute to a variety of human diseases. Mutations in different PKA subunits manipulate PKA dynamics and activities and contribute to specific disease patterns.
Mutations activating cAMP/PKA signaling contribute e.g. to carcinogenesis or degenerative diseases, while inactivating mutations cause e.g. hormone resistance [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
Therefore, revealing the composition of signaling complexes formed upon GPCR and kinase activation is critical for understanding the modes of kinase activation. In-depth analyses of transient protein:protein interactions (PPIs) along with the phosphorylation dynamics have the potential to reveal conditional signal flow and thus may help to explain
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Page 4 of 26 pathological implications of second-messenger signaling. Such a strategy will lead to a better understanding of cAMP-signaling, which boosts proliferation in many cell types but inhibits cell growth in others [28] [29] [30] [31] . Using a proteomics approach we have identified a physical and functional interaction of an orphan GPCR with distinct PKA subunits. We demonstrate that GPR161 is both a type I AKAP and a PKA substrate.
Results.
Protein:protein interaction (PPI) information is typically generated in exogenous systems such as the yeast two-hybrid approaches or from affinity purification followed by mass spectrometry of overexpressed tagged proteins 32 . Here, we affinity-purified endogenous PKA complexes from the osteosarcoma cell line U2OS after simulation of chronic stress conditions by selective activation of 2AR; a GPCR linked to cAMPmobilization and PKA activation 10 . We applied PKA-selective Rp-8-AHA-cAMP-agarose resin to isolate endogenous PKA complexes under varying ligand occupancies and timings of cAMP-generating ACs and endogenous AR from U2OS cells. Following proteomic and phospho-proteomic analyses (liquid chromatography -mass spectrometry), we generated an integrated PKA PPI network representing a consistent set of PKA associated proteins linked to PKA signaling: We confirmed the enrichment of all four PKA regulatory subunits (RI,RI, RII, RIIand two PKA catalytic subunits (PKAc). We organized the interaction partners in a fan-shaped pattern surrounding the centered PKA subunits providing a combined overview of 92 affinity-purified proteins using Rp-8-AHA-cAMP-resin (Supplementary Fig. 1&2 ; Supplementary Table 1; Supplementary information). However, to ease the selection of functionally linked PKA interactors we mapped all the detected phosphorylation sites and present co-purified phospho-proteins with their identified sites in a PKA centric illustration including 76 known phosphorylation and 33 potential PKA group phosphorylation sites (Fig. 1a) . With the Rp-8-AHA-cAMP bound PKA subunits we co-precipitated the AKAPs 1,2,3,5,8,9&11, which are known binary interaction partners of R subunits, along with further components of the cAMP machinery (PDE4A, PDE4IP) and kinase signaling. We discovered that these AKAP-organized PKA complexes contain additional proteins involved in protein transport, RNA binding and discrete posttranslational modifications (e.g. HDAC6 and PRMT6). Our analyses identified a large set of proteins attributed to metabolic signaling, thus underlining established and revealing novel connections of PKA to metabolic pathways.
Interestingly, also not easy accessible interactors like membrane receptors and channels (e.g. GPR161, ADORA3 and TRPC3, KCNJ3) were identified in the macromolecular PKA complex. This observation prompted us to characterize an unforeseen physical link to a membrane protein, the orphan GPCR GPR161, which actually contains a canonical PKA phosphorylation consensus site in its carboxy-terminus (CT, ... 427 RRSS 430 …). This decision was endorsed by previous studies and observations: First, it has been previously shown that the GPR161-CT is critically implicated in developmental processes (lens development, neurulation) through implications in GPR161 localization (Fig. 1b) 33 .
Second, both GPR161 and PKA activities are involved in hedgehog signaling in the primary cilium (Fig. 1b) 34, 35 . Third, a physical connection of PKAc with GPR161 has been proposed in a recent network study using tagged PKA subunits as bait 36 . Fourth, upregulated GPR161 expression patterns have been found in triple negative breast cancer 37 . This begs the questions how physical PKA associations with this orphan receptor (indirect or direct?) might contribute to GPR161 functions.
To facilitate the analyses of the function of the cytoplasmic localized GPR161-CT (=CT 342-529 ), we generated different glutathione-sepharose-transferase (GST) expression constructs to investigate complex formation with PKA. In GST pulldown assays we precipitated endogenous PKA subunits from HEK293 cell lysates with GST-CT 342-529 . We significantly enriched endogenous RI:PKAc complexes. No binding of RIIwas detectable. Addition of excess of cAMP to the precipitation reaction initiated PKA complex dissociation. In contrast to diminished PKAc binding, the GST-CT 342-529 :RI complex was insensitive to cAMP-binding (Fig. 1c) . These data underline that binding of PKAc to GPR161 is mediated through RI subunits. To determine specific amino acids in GPR161 that are responsible for RI binding we performed a peptide spotting experiment. We spotted overlapping 25-mer peptides derived from GPR161-CT 342-529 sequence onto a membrane and overlaid it with recombinant RI-his 6 (hexa-histidine tagged), as previously described 38 . In the GPR161-CT we identified one possible binding site for RI with the core region …LDSYAASLAKAIE… (Fig. 1d) . This sequence stretch is part of an amphipathic helix with the centered Leu465 (Fig. 1e) which we substituted in the next experiments for proline. With different recombinant GST-CT variants of GPR161 we repeated the pulldown experiments with recombinant RI in vitro. We confirmed the binary interaction of RI with wild type GPR161-CT 342-529 , and once again this complex is insensitive to cAMP binding to RI. All shorter variants of GPR161-CT which contain the core LAKAIE motif showed interaction with recombinant RI. The GST-CT 342-529 mutant containing the L465P substitution showed no binding to RI (Fig. 2a) . These experiments confirmed a binary PPI, GPR161-CT:RIin vitro. Moreover, it proved that an amphipathic helix in the GPCR-CT directly mediates PPI with type I PKA R subunits as it has been described in detail for all other members of the AKAP family.
We next repeated the experiment with cell lysates. We observed a similar pattern of PPI with RI. Endogenous RII did not bind to any of the GST-fused CTs (Supplementary Fig. 3a) . With overexpressed GPR161 variants we repeated cAMPprecipitation experiments as performed for Fig. 1a and Supplementary Figs.1&2 . We show that cAMP-bound R subunits are sufficient for the precipitation of full-length GPR161 tagged with Venus YFP. In comparison, the GPT161-CT mutant (L465P) showed no PPI (Supplementary Fig. 3b ). This data confirms our peptide array experiments and demonstrates that the CT mediates binary PPI with RI PKA subunits in cells.
Next we tagged the CT 378-529 N-and C-terminally with hexa-histidine tags (his 6 ) to increase its solubility. In contrast to the CT 378-529 L465P mutant, sole expression of the wild type fusion protein in bacteria showed low solubility. However, following bacterial coexpression of CT and untagged RI we observed enhanced solubility of the CT . Strikingly, in affinity purifications using Ni-NTA resin we co-purified significant amounts of untagged RI with CT 378-529 ; we observed no PPI with the L465P mutant CT of GPR161 (Fig. 2b) . A subsequent cAMP-precipitation showed the stability and specificity of this binary PPI in vitro (Supplementary Fig. 4) . The significant enrichment of RI with his 6 -CT 378-529 his 6 suggests that a ratio of CT:RIcomplexes of 1:2 is favored. This would underline the AKAP concept describing that one R subunit dimer interacts with the GPR161-AKAP helix. In dot blot analyses we compared binding of recombinant RI to amphipathic helices of selected AKAPs 39 . We observed that binding of RI also depends on the length and on the positioning of critical amino acids of the selected amphipathic helices. In this in vitro assay we confirmed specific binding of RItosequences surrounding the LAKAIE motif; binding was abolished with peptides containing proline substitutions (Supplementary Fig. 5 ). To understand the specificity of GPR161-CT binding we analyzed the helical propensity of GPCR161-CT with Agadir, an algorithm that predicts the helical content of peptides 40 . The -helix is predicted to span from D459 to L477. The modified L465 is located in the middle of the helix (Supplementary Fig. 6a ).
In structure-based alignments of GPR161 with RI specific AKAPs and dual specific AKAPs we identified residues that are similar and bind the D/D domain hydrophobic groove (shown in red; Fig. 2c ). RII specific AKAPs do not align the same way (Supplementary (Fig. 2d) . These hydrophobic residues are conserved in RI specific AKAPs (shown as surfaces in Fig. 2d ). All other GPR161 specific residues, within the predicted helix, which do not align with other RI specific AKAPs and are solvent exposed (shown in cyan). Next, we subjected the corresponding peptide CT 459-477 to fluorescence polarization measurements with full length RI or RII. We observed selective and high affinity binding of the peptide to RI with a Kd of 6.039 nM (±0.105). With RII homodimer we observed no binding (Fig. 2e) . This is in agreement with the pulldown assays illustrated in Fig.1c (Fig. 2f) .
To investigate the function of PKA:GPR161 interaction we analyzed the dynamics of receptor localization and phosphorylation. Fig. 3a depicts sequence elements in the GPR161-CT which we analyzed. As starting point we constructed mammalian expression vectors of different GPR161-variants tagged with Venus-YFP at the carboxy-terminus. We tested the consequence of general and GPCR-mediated cAMP-elevation on GPR161 phosphorylation. We transiently overexpressed Venus-YFP tagged wild type receptor along with the S429A/S430A and L465P mutants in HEK293 cells stably expressing 2 adrenergic receptors (2AR). 2AR are coupled to the stimulatory G protein s (Gs) and therefore are linked to cAMP elevation. We elevated cellular cAMP-levels with Forskolin and/or the AR ligand Isoproterenol. Following immunoprecipitation of the GPR161 variants we tracked changes of the phosphorylation status of GPR161 variants with a general PKA substrate antibody. In contrast to the L465P mutant we showed that the overexpressed wild type and S429A/S430A receptor bind endogenous RI. Upon cAMPelevations we observed a significant elevation of GPR161 phosphorylation. With the GPR161-S429A/S430A mutant, however, we detected no phosphorylation signal at all, underlining that S429/S430 is the target for PKA phosphotransferase activities (Fig. 3b,   Supplementary Fig. 7a ). Moreover, the L465P receptor mutant -which does not compartmentalize PKA complexes -showed a significant reduction of GPR161 phosphorylation following cAMP-elevation (Fig. 3b) . The PKA mediated phosphorylation of GPCR-CT is regarded as one general principal of controlling GPCR desensitization 8, 9, 42, 43 . Therefore, these data underline that the GPR161 compartmentalized type I PKA activities directly sense and integrate cAMP-oscillations which affect receptor phosphorylation and localization. To underline that the CT is critical for cellular GPR161:PKA complexes we used the Venus-YFP tagged receptor constructs for coprecipitation studies. In immunoprecipitations of GPR161-wt we co-purified cAMPdependent PKA complexes. The GPR161-CT variant showed no PPI with PKA subunits (Supplementary Fig. 7b) . The same constructs were tested in localization studies. The wild type receptor and the S429A/S430A mutant were mainly localized to cytoplasmic compartments. In agreement with previous studies 33 the GPCR161 variant which lacks the CT (GPR161-CT) was primarily localized to the plasma membrane ( Supplementary   Fig. 7c ). To ease co-localization studies with RI-GFP we tagged full length receptors at the carboxy terminus with mCherry. Following transient overexpression of the GPR161 variants in single transfection studies we confirmed cytoplasmic accumulations of the receptor with all three used mutants. RI-GFP was found throughout the cytoplasma with highly specific speckled/punctuate localizations (Fig. 3c) . Interestingly, upon coexpression of the wt and SS429AA receptor the a proportion of the GPR161:RI complex was recruited to the plasma membrane. Strikingly, with the GPR161-L465P mutant we detected no co-localization nor membrane recruitment (Fig. 3d) . These data underline an involvement of RI subunit binding in membrane targeting of GPR161.
The involvement of GPR161 in cilium signaling has been shown previously. Therefore we determined the localization of GPR161:RI directly in Zebrafish embryos. We observed that overexpression of the mCherry tagged wild type GPR161initiated receptor mediated PKA recruitment into the primary cilium of zebra fish embryos. In the experiments with the L465P mutant we observed significantly less cilium staining of GFP tagged RI (Fig. 3e Pia your turn).
Next we applied a Renilla luciferase (Rluc) based protein-fragment complementation assay (PCA) to confirm that binary GPR161:RI interactions are formed directly in the living cell (Fig. 4a) . Besides quantification of RI homodimer formation we illustrate specific binding of RIα to GPR161 in HEK293 cells. With the GPR161-L465P mutant the PPI signal decreased significantly (Fig. 4b) . To our surprise we also detected GPR161 dimerization using this cellular PPI reporter. Application of L465P mutants rather showed an increase of GPR161 dimers. However, the functional consequence of this observation needs to be evaluated. As predicted we observed that elevation of cAMP-levels triggered PKA complex dissociation of RI:PKAc. We could not detect a major impact of cAMP elevation on the GPR161:RI complex (Supplementary Fig. 8 ). We also wanted to test how far disease mutations of RI and RI affect the complex formation with the AKAP GPR161.
Through the N terminal dimer and docking domain, R subunit dimerizes and interacts with amphipathic helices of AKAPs 14, 44 . Therefore a perturbation of the integrity of the dimer and docking region would specifically affect AKAP interaction. Recently the patient mutation L50R in the D/D region of RIβ has been associated with a neurodegenerative disorder causing accumulations of RIβ in neuronal inclusions 27 . Using the Rluc PCA reporter we showed that RI specifically binds to GPR161. Application of the RIβ[L50R] mutant significantly decreased RIβ homo-dimerization (Fig. 4c) . It is the amino acid substitution directly in the antiparallel four helix bundle in the dimer/docking of RI dimers which is responsible for complex disruption. Dimer formation of R subunits is also a precondition for AKAP binding. In the Rluc PCA measurements we observed a substantial reduction of RIβ[L50R]:GPR161 complexes (Fig. 4c) . This experiment further underlines that GPR161 acts as type I AKAP. Next, we also wanted to test a link to better characterized patient mutations in the PRKAR1A gene. A collection of RI mutations have been linked to distinct disease phenotypes 17, 20, [24] [25] [26] [45] [46] [47] [48] [49] [50] . In the recent years a growing number of RIdisease mutations from Acrodysostosis and Carney complex patients have been made public. In contrast to perturbations of R dimerization, the tested RI mutations either affect cAMP binding or -in the case of the Carney complex mutant R74C -the mode of action is still controversial. We quantitatively evaluated the impact of all three RI mutations by analyzing complex formation with GPR161. We showed that neither the Carney complex mutation (R74C) nor the Acrodysostosis mutations (R335P, R368X) significantly changed the complex formation with GPR161 (Fig. 4d) mutated PKA type I complex (which actually still interacts with GPR161) is less responsive to beta-adrenergic receptor initiated cAMP-elevations (Fig. 4d) . The R335P mutation is sufficient to impair the cAMP-dependent dissociation of PKAc from RI. These data underline that GPR161 binds mutated RI holoenzyme complexes which are less reactive to cAMP controlled PKA activation. We assume that in a pathological cell setting such GPR161-anchored PKA complexes would be insensitive to transient cAMP-elevations thereby reducing or preventing PKA substrate phosphorylation.
Conclusion.
The idea that scaffolding proteins act as organizing centers to converge and redirect the information flow has evolved during the last two decades 4, 7 . Diverse scaffolds assemble flexible signaling nodes consisting of GTPases, kinases and phosphatases spatially and temporally. In the classical view scaffolds like the AKAP family, beta-arrestin, Ksr1 or PSD-proteins act as flexible connecting pieces between receptors and downstream effectors 1, 2, 4, 51 . Here we illustrate that one orphan GPCR by itself contains all the structural features that allow to be a high affinity anchoring protein (AKAP) for type I PKA. Several examples how selective AKAPs recruit type II PKA to distinct membrane receptors have been illustrated 14, 52, 53 54 . Here we present the discovery of a binary receptor-kinase interaction which opens new possibilities for anchoring and receptormediated compartmentalization of PKA contribute to physiological but also pathological receptor and kinase functions. This demonstrates that PKA type I compartmentalization is essential for efficient receptor phosphorylation which is a general principle for controlling receptor desensitization 8, 9, 42, 43 . An additional function of the binary GPR161-PKA interaction is the targeting of receptor-kinase complexes to the plasma membrane. The mode of action is still elusive. Interestingly, in a recent study GPR161 expression levels have been correlated with aberrant proliferation in triple negative breast cancer cells 37 .
This observation and our findings that exclusively type I PKA regulatory subunits (RI) bind to the membrane receptor motivated us to test GPR161 interactions with mutated and disease relevant RI subunits. Several genetic defects in distinct PKA subunits have been revealed. Both kinase inactivating and activating mutations have been described. Figure 4) . Such an interaction would desensitize compartmentalized GPR161-PKA complexes for cAMP-activation in case of Acrodysostosis. In addition we showed that a point mutation in the PRKAR1B gene (RI[L50R]), which is associated with neurodegenerative diseases 27 , diminished PPI with GPR161. We speculate that such a dominant negative function of RI subunits would dramatically decrease the complex formation of wild type RI subunits involved in dimer formation with the AKAP-receptor.
Therefore we recommend that this new and high affinity RI scaffolding function of GPR161 needs to be considered in analyses of spatiotemporal cAMP-dynamics in diseases with PKA dysfunction.
Recent evidence illustrated that localized GPR161 functions are associated with hedgehog signaling in the primary cilium 34 . Indeed, we showed in a model organism that GPR161 targets RI to the cilium. Primary cilia are platforms for seven-transmembrane spanning receptor cascades including the hedgehog-linked smoothened pathway (Smo), which antagonizes cAMP-signaling. GPR161 activities seem to be the long-sought factors for creating spatiotemporal controlled cAMP-gradients in the ciliary hedgehog signaling pathway 55, 56 . In the primary cilium compartment cAMP-elevating GPR161 activities negatively regulate hedgehog signaling. Interestingly, activation of the counteracting hedgehog pathway triggers the removal of GPR161 from the cilium 34 . Our discovery has considerable consequences for the cilium signaling: First, the AKAP motif embedded within the GPR161 tail recruits and compartmentalizes cAMP-sensing type I holoenzymes into the plasma membrane of the cilium. Second, hedgehog ligands antagonize ciliary pools of GPR161 and most probably also receptor-interacting PKA activities. Overall we believe that the ciliary signaling complex consisting of cAMP-sensing GPR161-PKA is the missing link to integrate cAMP levels, compartmentalized PKA activities, and counteracting Smo signaling. A variety of ciliary dysfunctions, termed ciliopathies have been described 55, 57 . Both, the involvement of spatiotemporal cAMP-dynamics and the integrity of GPR161-PKA complexes need to be considered in molecular analyses of selected ciliopathies. In this context the smoothened receptor, a key component of seventransmembrane receptors signaling in the primary cilium, is already a central target for cancer drug discovery efforts 58 . We assume that pharmacological targeting of the AKAP and/or the receptor function of the G-alpha-s coupled GPR161 receptor is one strategy to redirect decontrolled cAMP signaling. We hypothesize that besides direct pharmacological perturbation of receptor or kinase activities the ubiquitination of receptor interacting RI subunits is a feasible and alternative approach for controlling GPR161-PKA localization and signaling. Praja2 has been recently identified to be the major E3 ligase for PKA RI subunit ubiquitination 59 . It has been shown that PKA activities enhance praja2 mediated degradation of phosphotransferase inhibitory PKA RI subunits leading to enhanced PKAc activities 59 . We speculate that degradation of R subunits is an alternative direction to impact GPR161 signaling. Taken together, we propose that the binary GPR161-PKA complex is a compartmentalized signaling hub that directly integrates receptor-sensed input signals with spatiotemporal cAMP dynamics. So far GPR161 is the first GPCR shown to have an AKAP function. Given that GPCRs are the largest family of cell surface molecules involved in signal transmission, it would be surprising if GPR161 is the 'lone wolf' with AKAP function amongst more than 800 GPCRs in the human genome 60 . However, if this is the case then it would further emphasize its critical and kinasecompartmentalizing receptor function. Biotech International) with 15 strikes (standard lysis buffer: 10 mM sodium phosphate pH 7.2, 150 mM NaCl, 0.5% Triton-X100 supplemented with standard protease inhibitors and phosphatase inhibitors). We clarified the lysate (13 000 rpm, 15 min) and precipitated endogenous PKA regulatory subunit associated protein complexes with PKA selective Rp-8-AHA-cAMP agarose resin (Biolog, #A012) for two hours at 4°C. As negative control experiment we added excess of cAMP (1 mM) to the lysates to mask the cAMP binding sites in the R subunits for precipitation. Resin associated proteins were washed four times with standard lysis buffer and eluted with 1% SDS. Following SDS removal (using SDS removal columns; Calbiochem, # 263454) we analyzed the proteomic and phosphoproteomic composition of bead associated complexes as previously described 62 . We followed the same cAMP-precipitation protocol following transient overexpression of GPR161 variants in HEK293 cells. This time resin associated proteins were subjected to SDS-polyarylamid gel electrophoresis followed by immunoblotting.
LC-MS/MS analyses.
We were interested in both protein identity and protein phosphorylation: therefore we split the samples (83-250 µg each) and enriched 80% of the trypsin-digested material with titanium dioxide for phospho-peptide identification. The remaining 20% of the isolated material was used for the identification of bound proteins using LC-MS/MS. All experiments were performed as independent experiments and/or as independent triplicates. Tryptic digests and enriched phosphopeptides were analyzed on the LTQ-Orbitrap XL mass spectrometer (Thermo Fischer Scientific) coupled to a nanoflow LC system (Eksigent). Peptides were first trapped on a reverse-phase pre-column (4mm length, 360 mm i.d.) and then separated on the analytical column (10 cm length, 150 mm i.d.) (Jupiter C18, 3mm, 300 Angstrom (A°), Phenomenex) using an acetonitrile gradient ranging from 2 to 33% over 53 min at 600 nL/min. MS instrument was operated with the nano-electrospray source voltage set to 1.7 kV, MS scan resolution to 60 000 (lock mass activated) and CID MS/MS spectra were acquired on data-dependent acquisition mode for the three most abundant precursor ions (5 000 counts intensity threshold) 62 .
MS data processing. Acquired MS/MS spectra were pre-processed with Mascot Distiller v2.1.1 (Matrix Science) and the generated MGF files were searched with Mascot 2.1 on a concatenated target/decoy IPI human database v3.37 (34 584 protein sequences).
Search parameters were as follow: precursor mass tolerance ±10 p.p.m., peptide fragment mass tolerance ±0.5Da, trypsin (two missed cleavages), and these variable modifications: carbamidomethyl (C), deamidation (NQ), oxidation (M), phosphorylation (STY). ProteoConnections, our in house bioinformatics software for phosphoproteomics analysis, was used to limit peptide FDR to 1%, to assess phosphorylation site localization confidence and to annotate previously reported phosphorylation sites. High abundant proteins were removed from the data (i.e. > 400000 copies per cell) 63 , then label-free quantification of peptides was performed 62, 64 . Programs were implemented in Python1, with some analyzes conducted with R2.
Motif detection. We searched motifs with motif-x and we pre-aligned our identified phosphosites with a width of 15 amino acids as input and the IPI human proteome as background data 65 .
In vitro protein binding assays. We cloned coding regions of indicated aa stretches of the GPR161-CT (murine, ABO93465.1) into the pGEX-5X1 vector using flanking EcoRI/XhoI restriction sites. All GST-hybrid proteins were expressed in Escherichia coli (strains: BL21-DE3-RIL, Rosetta pLysS). Induction, cell lysis and affinity purification of hybrid proteins were performed as recommended by the supplier of the pGEX vectors (GE Healthcare). GST hybrid proteins (GST, GST-CT variants) immobilized on glutathione beads were incubated with cell lysates from HEK293 cells (DMEM medium supplemented with 10% FBS) for three hours. Resin-associated complexes were washed at least four times with the standard lysis buffer (10 mM sodium phosphate pH 7.2, 150 mM NaCl, 0.5% Triton X100) and eluted with Laemmli sample buffer (2% SDS, 50 mM Tris HCl pH 6.8, 0.2 mg/ml bromphenol blue, 0.1 M DTT, 10% (v/v) glycerol).
Protein expression and purification. To obtain the prokaryotic expression vectors pET11d-RIα-his6 and pET11d-RIα the human coding region (PKA RIα, NP 002725.1) was PCR-amplified using oligonucleotides with or without the C-terminal his 6 -tag followed by insertion into the multiple cloning site of the pET11d vector (Stratagene). Expression of recombinant proteins was performed in the Escherichia coli strain Rosetta pLysS (Novagen) at 30°C for 6 hours in LB medium. We purified PKA RIα-his 6 protein by affinity chromatography according to supplier's instructions for the Ni-NTA spin kit (Qiagen) followed by a size exclusion chromatography using an ÄKTA Superdex-75 gel filtration column (GE Healthcare). To obtain the double-his6 tagged prokaryotic expression vector construct pET30a-GPR161-CT 378-528 , the murine coding region (GPR161, ABO93465.1) was PCR-amplified followed by insertion into the multiple cloning site (BglII/XhoI) of the pET30a vector (Novagen). The L465P mutations was inserted via site directed mutagenesis. Co-expression of untagged RI and his 6 -CT 378-528 -his 6 proteins were performed in Escherichia coli strain BL21-DE3-RIL at 30°C for 3 hours (1 mM IPTG) in LB medium containing both ampicillin and kanamycin antibiotics. Subsequently, the co- Imaging. Life cell imaging have been performed using a Leica TCS SP5 II inverse laser scanning microscope. The settings for co-localization experiments were as followed:
Johanna Even following single transient transfections (24h, 48h) we examined both mCherry and GFP fluorescence to control specificity of excitation and emission.
Renilla luciferase PCA. The Rluc PCA based hybrid proteins RIIb-F [1] and PKAc-F [2] have been designed as previously described 68 . Rluc PCA fusions GPR161 have been generated using an analogous cloning approach. Following PCR amplification of the of the GPR161 gene we fused them C-terminally with either -F [1] Supplementary Figure 8 
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